Login
Home / 001065.KS : KSC
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

JW Pharmaceutical Corporation

₩22350 -$6250.00 (-21.85%)
KSC · 15 Sep 2026 06:30 UTC
Previous Close
₩22400
Day Range
₩22200₩22350
Year Range
₩19710₩30300
Market Cap
394.29B
AVG Volume
279
Trailing/Forward PE
6.46/5.61
PEG ratio
0.76
Dividend Yield
2.40%
Next Earnings Date
-
Primary Exchange
Korea ExchangeKR
Revenue (KRW)
0100B200B300B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Net Income (KRW)
-10B010B20B30B40B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Operating Income (KRW)
010B20B30B40B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EBITDA (KRW)
010B20B30B40B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash Flows (KRW)
-20B020B40B60B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPS (KRW)
-50005001000150024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Expenses (KRW)
020B40B60B80BR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash & Debt (KRW)
050B100B150BCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Debt ratios
-0.500.5124 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Margins
0%20%40%60%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Return on Capital
-2.5%0%2.5%5%7.5%10%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Shares Outstanding
010M20M30M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Dividends (KRW)
0200400600800Dec 16Dec 17Dec 18Dec 19Dec 20Dec 21Dec 22Dec 23Dec 24Mar 26
Book Value Per Share (KRW)
0500010000150002000024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Total Assets (KRW)
0200B400B600B800B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PE Ratio
510152025med 10.41Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Free Cash Flow Yield
0%5%10%15%20%med 9.14%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price to Sales
0.40.60.81med 0.9Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
EV/EBITDA
46810med 6.09Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price/Operating Cashflow
57.51012.515med 7.66Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price to Book
11.522.53med 1.98Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
JW Pharmaceutical Corporation
001065.KS
Stockpicker

Video analysis: 001065.KS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.